Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib vs Methotrexate in Psoriatic Arthritis
NCT03736161Phase 3Completed
- Sponsor
- Globe Pharmaceuticals
- Start
- Sep 2017
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tofacitinib in psoriatic arthritis (PsA), sponsored by Globe Pharmaceuticals. Started Sep 2017; status: completed.
02
Drugs
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT03736161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03736161.